Ophthalmology and Visual Sciences

Our nationally renown ophthalmologic specialists offer patient care in the following areas general ophthalmology, pediatric ophthalmology, cornea, retina and refractive surgery, glaucoma, optometry, neuro ophthalmology, oculoplastics, ocular oncology and pathology. Whether you need a routine eye exam or a refractive surgeon, there is a physician in our Department who can provide for your eye health care needs.

Text Size: S M L

Home > Physicians Directory > Ophthalmology and Visual Sciences

Kevin J. Blinder, MD

Specialty Areas
Retina
Ophthalmology, Retina

Areas of Clinical Interest
Diabetic retinopathy, macular surgery, macular holes, macular pucker, age-related macular degeneration, vitreous substitutes, retinal detachments



Major or Recent Publications/Awards
Honors and Awards
Listed in Best Doctors in America, 2005 - 2008 (Best Doctors, Inc)
The American Academy of Ophthalmology Achievement Award, 2002
Vitreous Society Honor Award, 2001

Book Chapters
Diabetes and the Eye. Duanes Clinical Ophthalmology. In Press.

Use of Perfluorocarbon Liquids, Vitreoretinal Surgical Techniques, Martin Dunitz Publishers, 2006.

Retinal Lasers: Laser Types, Instrumentation, Uses, and Tissue Interactions. Ophthalmic Hyperguide, Clinical Optics Module. Slack Inc., 2001.

Use of Perfluorocarbon Liquids, Vitreoretinal Surgical Techniques, Martin Dunitz
Publishers, May, 2000

Journal Articles
Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA. Intravitreal Bevacizumab Combined with Verteporfin Photodynamic Therapy for Choroidal Neovascularization in Age-related Macular Degeneration. Retina 2008; 28:675-681.

Schadlu R, Blinder KJ, Shah GK, Holekamp NM, Thomas MA, Grand MG, Engelbrecht NE, Apte RS, Joseph DP, Prasad AG, Smith BT, Sheybani A; Intravitreal Bevacizumab for Choroidal Neovascularization in Ocular Histoplasmosis. Am J Ophthalmol 145:875-878, 2008.

Tewari A, Shah GK, Dhalla MS, Blinder KJ: Surface Anesthesia for Office-Based Retinal Procedures. Retina 27:804-5, 2007.

Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 141:752-4, 2006.

Wickens J, Blinder KJ: A Preliminary Benefit-risk Assessment of Verteporfin in Age-Related Macular Degeneration. Drug Safety 29:189-199, 2006.

Hariprasad SM, Shah GK, Mieler WF, Feiner L, Blinder KJ, Holekamp NM, Gao H, Prince RA. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 124:178-82, 2006.

Hariprasad SM, Shah GK, Blinder KJ. Short-Term Intraocular Pressure Trends Following Intravitreal Pegaptanib (Macugen) Injection. Am J Ophthalmol 141:200-201, 2006.

Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA: Penetration Pharmacokinetics of Topically Administered 0.5% Moxifloxacin Ophthalmic Solution in Human Aqueous and Vitreous. Arch Ophthalmol 123: 39-44, 2005.

Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M. Triamcinolone-assisted internal limiting membrane peeling. Retina 25:972-5, 2005.

Shah GK, Blinder KJ, Hariprasad SM, Thomas MA, Ryan EH, Bakal J, Sharma S: Photodynamic Therapy for Juxtafoveal Choroidal Neovascularizaiton Due to Ocular Histoplasmosis Syndrome. Retina 25:26-32, 2005.

Blinder KJ, Shah GK, Thomas MA, Holekamp NM, Joseph DP, Grand MG, Sharma S. Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration. Ophthalmic Surg Lasers 36:358-64, 2005.

Rosenblatt BJ, Shah GK, Blinder KJ: Photodynamic Therapy with Verteporfin for Peripapillary Choroidal Neovascularization. Retina 25:33-37, 2005.